With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Cooperating Signaling Networks Regulate Cell Survival of Pediatric Ph-like ALL||University of Pennsylvania / Christian Hurtz, PhD||Young Investigator Grants||2018||Pennsylvania|
|COPE in Parents of Children Diagnosed with Cancer||University of Arizona / Gloanna Peek||Nurse Researcher Grants||2011||Arizona|
|Correction of Hematopoietic Defects in Down Syndrome by Chromosome 21 Silencing||University of Massachusetts Medical School / Peter Newburger, M.D.||Innovation Grants||2014||Massachusetts|
|Critical Contributions of CRM1 to Leukemogenesis||University of Vermont / Jessica Linda Heath, MD||Young Investigator Grants||2015||Vermont|
|Cure Osteosarcoma Lung Metastasis by Disrupting Tumor VCAM-1 Signaling with Macrophages||Case Western Reserve University / Alex Huang, MD, PhD||Innovation Grants||2015||Ohio|
|Dana-Farber/Children’s Hospital Cancer Center Developmental Therapeutics Center of Excellence||Dana-Farber Cancer Institute / Steven DuBois, MD & Wendy London, PhD - Scholars: Melissa Burns, MD; Kevin Campbell, MD; Natalie Collins, MD/PhD; David Shulman, MD||Center of Excellence Grants||2012||Massachusetts|
|De-escalation of Radiotherapy for Medulloblastoma by a Novel DNA Damage Checkpoint Inhibitor||Feinstein Institute for Medical Research - North Shore / Marc Symons, PhD||Innovation Grants||2017||New York|
|Deciphering the Mechanisms of Medulloblastoma Treatment Resistance using Integrative Genomics||Hospital for Sick Children / Vijay Ramaswamy, MD||Young Investigator Grants||2014||Ontario|
|Defining the Cell Surface Landscape of Diagnostic and Relapsed Neuroblastoma: Immunotherapeutic Target Identification||Children's Hospital of Philadelphia / Sharon Diskin, PhD||Innovation Grants||2017||Pennsylvania|
|Defining the Mechanism by which LIN28B acts as an Oncogene in Neuroblastoma||Children's Hospital of Philadelphia / Robert Schnepp, MD, PhD||Young Investigator Grants||2013||Pennsylvania|